Document Detail


The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.
MedLine Citation:
PMID:  22981405     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: p-Cresyl sulfate (PCS) and indoxyl sulfate (IS) have been reported to predict poor clinical outcomes in hemodialysis (HD) patients. However, little is known about the effect of the two toxins on peripheral arterial disease (PAD) and vascular access dysfunction. Our objective was to explore the association between the two toxins and PAD and vascular access failure (VAF) in a hemodialysis-based cohort.
METHODS: We enrolled 100 stable and eligible HD patients from a single medical center. These patients were screened for PAD by machine and recorded as ABI (ankle brachial index) and brachial-ankle PWV (pulse wave velocity). Serum levels of PCS, IS and biochemical data were also collected concurrently. In addition, we also recorded the first event of VAF and frequency of PTA and thrombectomy during 3-year follow-up.
RESULTS: Total and free PCS were correlated to right and left ABI and PWV (p < 0.01), and total IS was associated with right and left ABI (p < 0.01) by Pearson's analysis. Repeated measuring by mixed model analysis revealed that serum albumin (p = 0.003), cholesterol (p = 0.01) and total PCS (p = 0.031) had significant correlation with ABI after adjusting other confounding factors. As for brachial-ankle PWV, serum triglyceride (p = 0.002), total IS (p = 0.04) and total PCS (p = 0.050) reached significance finally. In addition, multivariate Cox regression analysis revealed dialysis length and total PCS were related to AV-shunt failure event (Hazard Ratio: 1.14, p = 0.01, and Hazard Ratio: 1.04, p = 0.04, respectively). Both of total and free PCS and IS were also positively linked to numbers of PTA and thrombectomy. Further, the Kaplan-Meier analysis showed only total PCS was significantly associated with vascular access failure event (log rank P = 0.02).
CONCLUSION: This study shows that the serum levels of PCS and IS were associated with PAD and total PCS could be a valuable determinant of access viability other than traditional or nontraditional risk factors in HD patients.
Authors:
Cheng-Jui Lin; Chi-Feng Pan; Hsuan-Liang Liu; Chih-Kuang Chuang; Thanasekaran Jayakumar; Tuen-Jen Wang; Han-Hsiang Chen; Chih-Jen Wu
Related Documents :
4060065 - Modified distal splenorenal shunt with expanded polytetrafluoroethylene interposition.
8905365 - Dieulafoy's disease: endosonographic detection and endosonography-guided treatment.
267295 - Alteration of primary hemostasis in hemophiliacs after treatment with lyophilized antih...
2129815 - Comparative efficacy of emergency endoscopic sclerotherapy for active variceal bleeding...
18572345 - Should acute treatment with inhaled beta agonists be withheld from patients with dyspne...
7951285 - Endopyelotomy in horseshoe kidneys.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-08-28
Journal Detail:
Title:  Atherosclerosis     Volume:  225     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-22     Completed Date:  2013-04-11     Revised Date:  2013-07-16    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  173-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Ankle Brachial Index
Cresols / blood*
Equipment Failure*
Female
Humans
Indican / blood*
Male
Middle Aged
Peripheral Arterial Disease
Pulse Wave Analysis
Renal Dialysis / adverse effects
Toxins, Biological / blood*
Vascular Access Devices / adverse effects*
Chemical
Reg. No./Substance:
0/4-cresol sulfate; 0/Cresols; 0/Toxins, Biological; 0/uremia middle molecule toxins; 487-94-5/Indican

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Caregiver Assistance Among Medicare Beneficiaries With Atrial Fibrillation and Factors Associated Wi...
Next Document:  Statins use and coronary artery plaque composition: Results from the International Multicenter CONFI...